Persistence of West Nile virus

Microbes and Infection

Volumn 17, Issue 2, 2015, Pages 163-168

  Garcia, Melissa N ^a   Hasbun, Rodrigo ^b   Murray, Kristy O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Morbidity; Mortality; Neurologic outcomes; Persistence; Renal outcomes; West Nile virus

Indexed keywords

ACUTE DISEASE; ARTICLE; COHORT ANALYSIS; FLAVIVIRUS INFECTION; HUMAN; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; OBSERVATIONAL STUDY; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; WEST NILE FLAVIVIRUS; WEST NILE FLAVIVIRUS INFECTION; ANIMAL; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE MODEL; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; UNITED STATES; VIROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; WEST NILE VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84921593829     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.12.003     Document Type: Article

References (83)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25.
2. Alehagen U., Dahlstrom U., Rehfeld J.F., Goetze J.P. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011, 305:2088-2095.
3. Anastasiadou A., Kakoulidis I., Butel D., Kehagia E., Papa A. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 2013, 17:e494-e497.
4. Appler K.K., Brown A.N., Stewart B.S., Behr M.J., Demarest V.L., Wong S.J., et al. Persistence of West Nile virus in the central nervous system and periphery of mice. PloS One 2010, 5:e10649.
5. Barzon L., Pacenti M., Franchin E., Pagni S., Martello T., Cattai M., et al. Excretion of West Nile virus in urine during acute infection. J Infect Dis 2013, 208:1086-1092.
6. Baty S.A., Gibney K.B., Staples J.E., Patterson A.B., Levy C., Lehman J., et al. Evaluation for West Nile Virus (WNV) RNA in urine of patients within 5 months of WNV infection. J Infect Dis 2012, 205:1476-1477.
7. Berg P.J., Smallfield S., Svien L. An investigation of depression and fatigue post West Nile virus infection. South Dakota Med J South Dakota State Med Assoc 2010, 63:127-129. 31-3.
8. Bhuvanakantham R., Cheong Y.K., Ng M.L. West Nile virus capsid protein interaction with importin and HDM2 protein is regulated by protein kinase C-mediated phosphorylation. Microbes Infect/Institut Pasteur 2010, 12:615-625.
9. Bigham A.W.B.K., Husain S., Emond M.J., Bofferding K.M., Gildersleeve H., Rutherford A., et al. Host genetic risk factors for West Nile virus infection and disease progression. PloS One 2011, 6:e24745.
10. Brinton M. The molecular biology of West Nile virus: a new invader of the western hemisphere. Annu Rev Microbiol 2002, 56:371-402.
11. Canada PHAo West Nile virus MONITOR: human surveillance 2013.
12. Cantile C., Del Piero F., Di Guardo G., Arispici M. Pathologic and immunohistochemical findings in naturally occuring West Nile virus infection in horses. Veterinary Pathol 2001, 38:414-421.
13. Carson P.J.B.S., Custer B., Prince H.E., Dunn-Williams J., Winkelman V., Tobler L., et al. Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis 2012, 18:684-686.
14. Carson P.J., Konewko P., Wold K.S., Mariani P., Goli S., Bergloff P., et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 2006, 43:723-730.
15. Cheong Y.K., Ng M.L. Dephosphorylation of West Nile virus capsid protein enhances the processes of nucleocapsid assembly. Microbes Infect/Institut Pasteur 2011, 13:76-84.
16. Chung W.M.B.C., Joyner S.N., Hughes S.M., Fomby T.B., Luby J.P., Haley R.W. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013, 310:297-307.
17. Control UCfD List of all bird species in which West Nile virus has been detected 2013.
18. Correale J., Villa A. Cellular elements of the blood-brain barrier. Neurochem Res 2009, 34:2067-2077.
19. Deardorff E., Estrada-Franco J., Brault A.C., Navarro-Lopez R., Campomanes-Cortes A., Paz-Ramirez P., et al. Introductions of West Nile virus strains to Mexico. Emerg Infect Dis 2006, 12:314-318.
20. Diniz J.A., Da Rosa A.P., Guzman H., Xu F., Xiao S.Y., Popov V.L., et al. West Nile virus infection of primary mouse neuronal and neuroglial cells: the role of astrocytes in chronic infection. Am J Trop Med Hyg 2006, 75:691-696.
21. Dusek R.J., McLean R.G., Kramer L.D., Ubico S.R., Dupuis A.P., Ebel G.D., et al. Prevalence of West Nile virus in migratory birds during spring and fall migration. Am J Trop Med Hyg 2009, 81:1151-1158.
22. Garcia M.N., Hause A.M., Walker C.M., Orange J.S., Hasbun R., Murray K.O. Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines. Viral Immunol 2014, 27:327-333.
23. German A.C., Myint K.S., Mai N.T., Pomeroy I., Phu N.H., Tzartos J., et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 2006, 100:1135-1145.
24. Gibney K.B., Lanciotti R.S., Sejvar J.J., Nugent C.T., Linnen J.M., Delorey M.J., et al. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis 2011, 203:344-347.
25. Gottfried K., Quinn R., Jones T. Clinical description and follow-up investigation of human West Nile virus cases. South Med J 2005, 98:603-606.
26. Green M.S., Weinberger M., Ben-Ezer J., Bin H., Mendelson E., Gandacu D., et al. Long-term death rates, West Nile virus epidemic, Israel, 2000. Emerg Infect Dis 2005, 11:1754-1757.
27. Hasebe R., Suzuki T., Makino Y., Igarashi M., Yamanouchi S., Maeda A., et al. Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein. BMC Microbiol 2010, 10:165.
28. Hayes E.B., Komar N., Nasci R.S., Montgomery S.P., O'Leary D.R., Campbell G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005, 11:1167-1173.
29. Hinckley A.F.O.L.D., Hayes E.B. Transmission of West Nile virus through breast milk seems to be rare. Pediatrics 2007, 119:e666-e671.
30. Iwamoto M.J.D., Guasch A., Trepka M.J., Blackmore C.G., Hellinger W.C., Pham S.M., et al. West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl J Med 2003, 348:2196-2203.
31. Kapoor H., Signs K., Somsel P., Downes F.P., Clark P.A., Massey J.P. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol Off Publ Pan Am Soc Clin Virol 2004, 31:289-291.
32. Klee A.L., Maidin B., Edwin B., Poshni I., Mostashari F., Fine A., et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004, 10:1405-1411.
33. Komar N.L.S., Hinten S., Nemeth N., Edwards E., Hettler D., Davis B., et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003, 9:311-322.
34. Kuno G., Chang G.J., Tsuchiya K.R., Karabatsos N., Cropp C.B. Phylogeny of the genus Flavivirus. J Virol 1998, 72:73-83.
35. Lindsey N.P., Sejvar J.J., Bode A.V., Pape W.J., Campbell G.L. Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Vector Borne Zoonotic Dis 2012, 12:230-235.
36. Lindsey N.P.S.J., Lehman J.A., Fischer M. Medical risk factors for severe West Nile virus disease, United States, 2008-2010. Am J Trop Med Hyg 2012, 87:179-184.
37. Lindsey N.P., Staples J.E., Lehman J.A., Fischer M. Surveillance for human West Nile virus disease - United States, 1999-2008. Morb Mortal Wkly Rep Surveillance Summ 2010, 59:1-17. (Washington, D.C.: 2002).
38. Liou M.L., Hsu C.Y. Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain. Cell Tissue Res 1998, 293:389-394.
39. Loeb M., Hanna S., Nicolle L., Eyles J., Elliott S., Rathbone M., et al. Prognosis after West Nile virus infection. Ann Intern Med 2008, 149:232-241.
40. Mann B.R., McMullen A.R., Swetnam D.M., Barrett A.D. Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health 2013, 10:5111-5129.
41. Murgue B., Murri S., Triki H., Deubel V., Zeller H.G. West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci 2001, 951:117-126.
42. Murgue B., Zeller H., Deubel V. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol 2002, 267:195-221.
43. Murray K., Walker C., Herrington E., Lewis J.A., McCormick J., Beasley D.W., et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010, 201:2-4.
44. Murray K.O., Garcia M.N., Rahbar M.H., Martinez D., Khuwaja S.A., Arafat R.R., et al. Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort. PloS One 2014, 9:e102953.
45. Murray K.O., Garcia M.N., Yan C., Gorchakov R. Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus. Am J Trop Med Hyg 2013, 89:996-1000.
46. Murray K.O.K.E., Baraniuk S., Herrington E., Carter H., Sierra M., Kilborn C., et al. Risk factors for encephalitis from West Nile Virus: a matched case-control study using hospitalized controls. Zoonoses Public Health 2009, 56:370-375.
47. Murray K.O., Resnick M., Miller V. Depression after infection with West Nile virus. Emerg Infect Dis 2007, 13:479-481.
48. Nash D., Mostashari F., Fine A., Miller J., O'Leary D., Murray K., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344:1807-1814.
49. Nolan M.S., Hause A.M., Murray K.O. Findings of long-term depression up to 8 years post infection from West Nile virus. J Clin Psychol 2012, 68:801-808.
50. Nolan M.S., Podoll A.S., Hause A.M., Akers K.M., Finkel K.W., Murray K.O. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PloS One 2012, 7:e40374.
51. Nolan M.S., Schuermann J., Murray K.O. West Nile virus infection among humans, Texas, USA, 2002-2011. Emerg Infect Dis 2013, 19:137-139.
52. O'Leary D.R., Kuhn Stephanie, Kniss K.L., Hinkley A.F., Rasmussen S.A., Pape W.J., et al. Birth outcomes following West Nile virus infection of pregnant women in the United States: 2003-2004. Pediatrics 2006, 117:e537-e545.
53. Papa A., Danis K., Athanasiadou A., Delianidou M., Panagiotopoulos T. Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 2011, 83:1857-1860.
54. Papa A., Testa T., Papadopoulou E. Detection of West Nile virus lineage 2 in the urine of acute human infections. J Med Virol 2014, 86(12):2142-2145.
55. Patnaik J.L., Harmon H., Vogt R.L. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 2006, 12:1129-1131.
56. Pealer L.N.M.A., Petersen L.R., Lanciotti R.S., Page P.L., Stramer S.L., Stobierski M.G., et al. West Nile transmission investigation team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003, 349:1236-1245.
57. Petersen L.R.C.P., Biggerstaff B.J., Custer B., Borchardt S.M., Busch M.P. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 2013, 141:591-595.
58. Pogodina V.V., Frolova M.P., Malenko G.V., Fokina G.I., Koreshkova G.V., Kiseleva L.L., et al. Study on West Nile virus persistence in monkeys. Arch Virol 1983, 75:71-86.
59. Prince H.E., Tobler L.H., Lape-Nixon M., Foster G.A., Stramer S.L., Busch M.P. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005, 43:4316-4320.
60. Prince H.E., Tobler L.H., Yeh C., Gefter N., Custer B., Busch M.P. Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 2007, 14:1228-1230.
61. Qian F.T.J., Yuan X., Nolan M., Murray K.O., Lee W.T., Wong S.J., et al. Immune markers associated with host susceptibility to infection with West Nile virus. Viral Immunol 2014, 27:39-47.
62. Rappole J.H., Derrickson S.R., Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 2000, 6:319-328.
63. Reimann C.A., Hayes E.B., DiGuiseppi C., Hoffman R., Lehman J.A., Lindsey N.P., et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg 2008, 79:974-979.
64. Reisen W.K. Ecology of West Nile virus in North America. Viruses 2013, 5:2079-2105.
65. Rodriguez Mde L., Rodriguez D.R., Blitvich B.J., Lopez M.A., Fernandez-Salas I., Jimenez J.R., et al. Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico. Vector Borne Zoonotic Dis 2010, 10:151-157.
66. Roe K., Kumar M., Lum S., Orillo B., Nerurkar V.R., Verma S. West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increasein multiple matrix metalloproteinases. J Gen Virol 2012, 93:1193-1203.
67. Roehrig J.T., Nash D., Maldin B., Labowitz A., Martin D.A., Lanciotti R.S., et al. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003, 9:376-379.
68. Saxena V., Xie G., Li B., Farris T., Welte T., Gong B., et al. A hamster-derived West Nile virus isolate induces persistent renal infection in mice. PLoS Negl Trop Dis 2013, 7:e2275.
69. Sejvar J.J. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007, 44:1617-1624.
70. Sejvar J.J., Bode A.V., Marfin A.A., Campbell G.L., Pape J., Biggerstaff B.J., et al. West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006, 12:514-516.
71. Sejvar J.J., Haddad M.B., Tierney B.C., Campbell G.L., Marfin A.A., Van Gerpen J.A., et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003, 290:511-515.
72. Siddharthan V., Wang H., Motter N.E., Hall J.O., Skinner R.D., Skirpstunas R.T., et al. Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. J Virol 2009, 83:4251-4261.
73. Smithburn K.C.H.T., Burke A.W., Paul J.H. A neurotropic virus isolated fromthe blood of a native of Uganda. Am J Trop Med Hyg 1940, 20:471-492.
74. Suen W.W., Prow N.A., Hall R.A., Bielefeldt-Ohmann H. Mechanism of West Nile virus neuroinvasion: a critical appraisal. Viruses 2014, 6:2796-2825.
75. Taheri S., Gasparovic C., Shah N.J., Rosenberg G.A. Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn Reson Med Off J Soc Magn Reson Med/Soc Magn Reson Med 2011, 65:1036-1042.
76. Takahashi H., Ohtaki N., Maeda-Sato M., Tanaka M., Tanaka K., Sawa H., et al. Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus. Microbes Infect/Institut Pasteur 2009, 11:1019-1028.
77. Tesh R.B., Siirin M., Guzman H., Travassos da Rosa A.P., Wu X., Duan T., et al. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 2005, 192:287-295.
78. Tonry J.H., Brown C.B., Cropp C.B., Co J.K., Bennett S.N., Nerurkar V.R., et al. West Nile virus detection in urine. Emerg Infect Dis 2005, 11:1294-1296.
79. Tonry J.H., Xiao S.Y., Siirin M., Chen H., da Rosa A.P., Tesh R.B. Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 2005, 72:320-324.
80. van der Meulen K.M.P.M., Nauwnck H.J. West Nile virus in the vertebrate world. Arch Virol 2005, 150:637-657.
81. Verma S., Lo Y., Chapagain M., Lum S., Kumar M., Gurjav U., et al. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the invitro blood-brain barrier. Virology 2009, 385:425-433.
82. Weatherhead J.E., G M., Hasbun R., Salazar L., Dimachkie M., Murray K.O. Long-term neurologic outcomes among patients with a history of West Nile virus infection 2014.
83. Xu Z., Waeckerlin R., Urbanowski M.D., van Marle G., Hobman T.C. West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins. PloS One 2012, 7:e37886.